An Interview with Dr. Adam Friedman
Pharmaceuticals & Biotechnology Editor | 03/10/2010
An interivew with Dr. Adam Friedman, Chief Resident at the Department of Dermatology at Albert Einstein College of Medicine, on sustained release of Nitric Oxcide from the Hybrid Nanoparticle Platform: A novel therapeutic strategy for cutaneus infections.
Download PDF Attachment